뉴스벤징가
AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study
· 발표
기사 요약
AstraZeneca and Amgen report positive Phase 3 Tezspire data, showing sustained remission in eosinophilic esophagitis patients over 52 weeks.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…